Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Recurrence 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Neuroblastoma 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Hematologic Neoplasms 2Transplant-Related Hematologic Malignancy 1Teratoma 1Sarcoma 1Rhabdomyosarcoma 1Neoplasms by Histologic Type 1Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1

Interventions

Magnetic Resonance Spectroscopy 8X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2LY3023414 2pembrolizumab 1neratinib 1cemiplimab 1brigatinib 1Watchful Waiting 1Vincristine 1Vemurafenib 1Temozolomide 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Granulocyte Colony-Stimulating Factor × 90 days × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡